Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Bimosiamose in Moderate to Severe COPD
NCT01108913Phase 2Completed
- Sponsor
- Revotar Biopharmaceuticals
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bimosiamose in chronic obstructive pulmonary disease (COPD), sponsored by Revotar Biopharmaceuticals. Status: completed.
02
Drugs
bimosiamose
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01108913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108913.